収益的支出の英語

医薬に係わる発明の特許権者は，規則の要求に従って又は機関が命令により要求した場合は，当該規則又は命令に特定された次に掲げる事項に関する情報及び書類を機関に提出しなければならない: (a) 特許権者のカナダにおける実施権者の特定 (b) 直接的であるか又は間接的であるかを問わず，カナダにおける医薬の販売から特許権者が得る収益及びその収益の出所の詳細，及び (c) 医薬に関する研究開発に関し特許権者がカナダで行った支出例文帳に追加

Sales and expense information, etc., to be provided (1) A patentee of an invention pertaining to a medicine shall, as required by and in accordance with the regulations, or as the Board may, by order, require, provide the Board with such information and documents as the regulations or the order may specify respecting (a) the identity of the licensees in Canada of the patentee; (b) the revenue of the patentee, and details of the source of the revenue, whether direct or indirect, from sales of medicine in Canada; and (c) the expenditures made by the patentee in Canada on research and development relating to medicine.発音を聞く  - 特許庁

規模別産業連関表を用いて大企業と中小企業に対する各需要項目の生産波及効果を比較すると、輸出、設備投資は大企業に対する生産波及効果が大きい一方で、民間消費支出や公的固定資本形成は中小企業に対する生産波及効果が大きいため、輸出、設備投資主導の成長は必然的に大企業・中小企業間の収益格差を拡大させると考えられる（第2-2-25図）。例文帳に追加

A comparison between the production ripple effects of specific demand components on large companies and small- and medium-sized companies, based on the inter-industry relations table by company size, shows that export and capital investment have larger production ripple effects on large companies, while the private sector consumption and public fixed capital formation have larger production ripple effects on small- and medium-sized companies. Thus, it is presumable that the growth directed by export and capital investment inevitably increases the disparity between large companies and small- and medium-sized companies (see Figure 2-2-25). - 経済産業省